Literature DB >> 2987613

Epizootiological observations of natural and experimental infection with sialodacryoadenitis virus in rats.

P N Bhatt, R O Jacoby.   

Abstract

The epizootiology of sialodacryoadenitis (SDA) was studied in experimentally and naturally infected rats. The infectivity of SDA virus (SDAV) in intranasally infected rats was lost by seven days after infection as determined by contact transmission. After experimental infection, SN antibody appeared earlier and titers were detectable longer than CF antibody. The prevalence of SN antibody-positive rats in naturally infected colonies remained high, whereas an increase in the prevalence of CF antibody-positive rats appeared to coincide with the introduction or resurgence of SDAV. A SDAV-free colony was established by allowing recovered dams to litter in a separate room. A spontaneous cessation of SDAV infection also was observed in an enzootically-infected colony. Clinical observations indicated that SDA can occur as a mild or asymptomatic disease, and that its clinical expression may vary from one inbred strain to another.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2987613

Source DB:  PubMed          Journal:  Lab Anim Sci        ISSN: 0023-6764


  4 in total

1.  Replication of sialodacryoadenitis virus in mouse L-2 cells.

Authors:  D Percy; S Bond; J MacInnes
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

2.  Modeling pandemic to endemic patterns of SARS-CoV-2 transmission using parameters estimated from animal model data.

Authors:  Sarah Mullin; Brent Vander Wyk; Jennifer L Asher; Susan R Compton; Heather G Allore; Caroline J Zeiss
Journal:  PNAS Nexus       Date:  2022-07-01

3.  Modeling SARS-CoV-2 propagation using rat coronavirus-associated shedding and transmission.

Authors:  Caroline J Zeiss; Jennifer L Asher; Brent Vander Wyk; Heather G Allore; Susan R Compton
Journal:  PLoS One       Date:  2021-11-23       Impact factor: 3.240

Review 4.  Ocular disease in rats: a review.

Authors:  David L Williams
Journal:  Vet Ophthalmol       Date:  2002-09       Impact factor: 1.644

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.